Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy

Ann Am Thorac Soc. 2018 Oct;15(10):1131-1136. doi: 10.1513/AnnalsATS.201806-400PP.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Asthmatic Agents / pharmacology*
  • Asthma / drug therapy*
  • Biological Products / pharmacology*
  • Drug Prescriptions / standards*
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Asthmatic Agents
  • Biological Products